Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program
Overview
- Response deadline
- 12:00 PM CDT
- Posted
- October 22, 2025
- Notice type
- Solicitation
- Set-aside
- No Set aside used
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- DEFENSE HEALTH AGENCY
- Place of performance
- San Antonio, Texas, 78230
- Last updated
- Nov 6, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- HT9402-25-Q-9404
- Notice ID
- 41d1ca6915d8421ea65f49a0de162da5
Description
The Department of Defense (DoD) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.
P&T COMMITTEE MEETING: The following November 2025 newly approved drugs will be reviewed:
a. Blujepa - Antibiotics - N/A
b. Brekiya - Migraine Agents - N/A
c. Dawnzera - Corticosteroids-Immune Modulators - Hereditary Angiodema Agents
d. escitalopram - Antidepressants and Non-opioid Pain Syndrome Agents - Selective Serotonin Reuptake Inhibitors
e. Exxua - Antidepressants and Non-opioid Pain Syndrome Agents - N/A
f. Leqembi IQLIK - Alzheimers Agents - N/A
g. ustekinumab-ttwe - Targeted Immunomodulatory Biologics - Interleukin 23
h. Wayrilz - Hematological Agents - Platelets
i. Zurnai - Alcohol Deterrants-Narcotic Antagonists - Narcotic Antagonists
j. Phyrago - Oncological Agents - Chronic Myelogenous Leukemia
k. Inluriyo - Breast Cancer Agents - Estrogen Receptor Antagonist
l. Enbumyst - Diuretics - N/A
The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-25-Q-9404.
Pre-quotation teleconference is on October 15, 2025. Details are stated in Part 2.4. Pre-Quotation Teleconference. Responses to the clinical questions in Part 3.4 shall be submitted via e-mail to the RFQ POC in Part 2.3.1., no later than the date stated in Part 2.3.2.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (17)
- Download
Amendment 0001.pdf
143 KBAdded in Solicitation version 3Posted - Download
A0001 Price List - Inluriyo - Breast Cancer Agents - ERA.xlsx
46 KBAdded in Solicitation version 3Posted - Download
RFQ HT9402-25-Q-9404 NAD.pdf
2.7 MBAdded in Solicitation version 1Posted - Download
Price List - Blujepa - Antibiotics - NA.xlsx
46 KBAdded in Solicitation version 1Posted - Download
Price List - Brekiya - Migraine Agents - NA.xlsx
46 KBAdded in Solicitation version 1Posted - Download
Price List - Dawnzera - CIM - Hereditary Angioedema Agents.xlsx
46 KBAdded in Solicitation version 1Posted - Download
Price List - escitalopram - Antidepressants Non-opioid Pain SYN - SSRI.xlsx
47 KBAdded in Solicitation version 1Posted - Download
Price List - Exxua - Antidepressants Non-opioid Pain SYN - NA.xlsx
47 KBAdded in Solicitation version 1Posted - Download
Price List - Leqembi IQLIK - Alzheimers Agents - NA.xlsx
46 KBAdded in Solicitation version 1Posted - Download
Price List - ustekinumab-ttwe - TIB - Interleukin 23.xlsx
50 KBAdded in Solicitation version 1Posted - Download
A-3 Price List - Wayrilz - Hematological Agents - Platelets.xlsx
46 KBAdded in Solicitation version 1Posted - Download
Price List - Zurnai - Alcohol Deterrants-Narcotic Antagonists - Narcotic Antagonists.xlsx
46 KBAdded in Solicitation version 1Posted - Download
Price List - Phyrago - Oncological Agents - Chronic Myelogenous Leukemia.xlsx
46 KBAdded in Solicitation version 1Posted - Download
Price List - Inluriyo - Oncological Agents - NA.xlsx
46 KBAdded in Solicitation version 1Posted - Download
Price List - Enbumyst - Diuretics - NA.xlsx
46 KBAdded in Solicitation version 1Posted - Download
Price Appendix FAQ NAD.pdf
231 KBAdded in Solicitation version 1Posted - Download
DoD Formulary Placement of FDA Newly Approved Drugs.pdf
83 KBAdded in Solicitation version 1Posted
Links (1)
- https://health.mil/PandThealth.milPosted
Lifecycle
- 1Version 1SolicitationArchived
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program
- 3Version 3SolicitationArchivedCurrent
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
HT9402-25-Q-9404
Archive Date
Apr 27, 2026
Office Address
AURORA, CO, 80011